首页> 外文期刊>Molecular pharmaceutics >Detection of endogenous K-ras mRNA in living cells at a single base resolution by a PNA molecular beacon
【24h】

Detection of endogenous K-ras mRNA in living cells at a single base resolution by a PNA molecular beacon

机译:通过PNA分子信标以单碱基分辨率检测活细胞中内源性K-ras mRNA

获取原文
获取原文并翻译 | 示例
           

摘要

Detection of mRNA alterations is a promising approach for identifying biomarkers as means of differentiating benign from malignant lesions. By choosing the KRAS oncogene as a target gene, two types of molecular beacons (MBs) based on either phosphothioated DNA (PS-DNA-MB) or peptide nucleic acid (TO-PNA-MB, where TO = thiazole orange) were synthesized and compared in vitro and in vivo. Their specificity was examined in wild-type KRAS (HT29) or codon 12 point mutation (Panc-1, SW480) cells. Incubation of both beacons with total RNA extracted from the Panc-1 cell line (fully complementary sequence) showed a fluorescent signal for both beacons. Major differences were observed, however, for single mismatch mRNA transcripts in cell lines HT29 and SW480. PS-DNA-MB weakly discriminated such single mismatches in comparison to TO-PNA-MB, which was profoundly more sensitive. Cell transfection of TO-PNA-MB with the aid of PEI resulted in fluorescence in cells expressing the fully complementary RNA transcript (Panc-1) but undetectable fluorescence in cells expressing the K-ras mRNA that has a single mismatch to the designed TO-PNA-MB (HT29). A weaker fluorescent signal was also detected in SW480 cells; however, these cells express approximately one-fifth of the target mRNA of the designed TO-PNA-MB. In contrast, PS-DNA-MB showed no fluorescence in all cell lines tested post PEI transfection. Based on the fast hybridization kinetics and on the single mismatch discrimination found for TO-PNA-MB we believe that such molecular beacons are promising for in vivo real-time imaging of endogenous mRNA with single nucleotide polymorphism (SNP) resolution.
机译:检测mRNA改变是一种有前途的方法,可用于鉴定生物标志物,以区别良性和恶性病变。通过选择KRAS癌基因作为靶基因,可以合成两种基于硫代磷酸化DNA(PS-DNA-MB)或肽核酸(TO-PNA-MB,其中TO =噻唑橙)的分子信标(MBs),在体内和体外进行比较。在野生型KRAS(HT29)或密码子12点突变(Panc-1,SW480)细胞中检查了它们的特异性。将两个信标与从Panc-1细胞系(完全互补的序列)中提取的总RNA一起温育,显示两个信标的荧光信号。然而,在细胞系HT29和SW480中观察到单个错配mRNA转录物的主要差异。与TO-PNA-MB相比,PS-DNA-MB几乎无法区分此类单一错配,后者的敏感性更高。借助PEI对TO-PNA-MB进行的细胞转染导致表达完全互补的RNA转录物(Panc-1)的细胞产生荧光,但表达K-ras mRNA的细胞中却检测不到荧光,该荧光与设计的TO- PNA-MB(HT29)。在SW480细胞中也检测到了较弱的荧光信号。然而,这些细胞表达设计的TO-PNA-MB的靶mRNA的大约五分之一。相反,PSI DNA-MB在PEI转染后测试的所有细胞系中均未显示荧光。基于快速杂交动力学和基于TO-PNA-MB的单个错配判别,我们相信此类分子信标有望以单核苷酸多态性(SNP)分辨率在体内实时成像内源性mRNA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号